Clinical Trial Update: Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias [Phase 1]

View source ↗

Summary

Phase 1 trial of mesenchymal stromal cells for COVID-19 pneumonia and viral pneumonia has been withdrawn. Sponsor: Medical University of South Carolina.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Mesenchymal stromal cells

Snippet

Sponsor: Medical University of South Carolina | Conditions: COVID-19 Pneumonia, Viral Pneumonia | Phase 1 | Status: WITHDRAWN